Preparation, Characterization and in vitro/in vivo Evaluation of Lovastatin-Loaded PLGA Microspheres by Local Administration for Femoral Head Necrosis

References

• YoshiiT, HafemanAE, EsparzaJM, OkawaA, GutierrezG, GuelcherSA. Local injection of lovastatin in biodegradable polyurethane scaffolds enhances bone regeneration in a critical-sized segmental defect in rat femora. J Tissue Eng Regen Med. 2014;8(8):589–595. doi:10.1002/term.154722718577
   PubMed Web of Science ®Google Scholar
• MurraySS, TuKN, YoungKL, MurrayEJB. The effects of lovastatin on proteasome activities in highly purified rabbit 20 S proteasome preparations and mouse MC3T3-E1 osteoblastic cells. Metabolism. 2002;51(9):1153–1160. doi:10.1053/meta.2002.3470612200760
   PubMed Web of Science ®Google Scholar
• Ghosh-ChoudhuryN, MandalCC, ChoudhuryGG. Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation. J Biol Chem. 2007;282(7):4983–4993. doi:10.1074/jbc.M60670620017179158
   PubMed Web of Science ®Google Scholar
• MaedaT, MatsunumaA, KurahashiI, YanagawaT, YoshidaH, HoriuchiN. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem. 2004;92(3):458–471. doi:10.1002/jcb.2007415156558
   PubMed Web of Science ®Google Scholar
• WongRWK, RabieAB. Early healing pattern of statin-induced osteogenesis. Br J Oral Maxillofac Surg. 2005;43(1):46–50. doi:10.1016/j.bjoms.2004.08.01415620774
   PubMed Web of Science ®Google Scholar
• WeisM, HeeschenC, GlassfordAJ, CookeJP. Statins have biphasic effects on angiogenesis. Circulation. 2002;105(6):739–745. doi:10.1161/hc0602.10339311839631
   PubMed Web of Science ®Google Scholar
• ChoiK-Y, KimH-J, LeeM-H, et al. Runx2 regulates FGF2-inducedBmp2 expression during cranial bone development. Dev Dyn. 2005;233(1):115–121. doi:10.1002/dvdy.2032315765505
   PubMed Web of Science ®Google Scholar
• BouletreauPJ, WarrenSM, SpectorJA, et al. Hypoxia and VEGF Up-Regulate BMP-2 mRNA and Protein Expression in Microvascular Endothelial Cells: implications for Fracture Healing. Plast Reconstr Surg. 2002;109(7):2384–2397. doi:10.1097/00006534-200206000-0003312045566
   PubMed Web of Science ®Google Scholar
• RaoS, TanA, BoydBJ, PrestidgeCA. Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin. Nanomedicine. 2014;9(18):2745–2759. doi:10.2217/nnm.14.3724938439
   PubMed Web of Science ®Google Scholar
• LennernäsH, FagerG. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinet. 1997;32(5):403–425. doi:10.2165/00003088-199732050-000059160173
   PubMed Web of Science ®Google Scholar
• ChenC-H, UangY-S, WangS-T, YangJ-C, LinC-J. Interaction between red yeast rice and CYP450 enzymes/P-glycoprotein and Its implication for the clinical pharmacokinetics of lovastatin. Evid Based Complement Alternat Med. 2012;2012:127043. doi:10.1155/2012/12704323227093
   PubMed Web of Science ®Google Scholar
• SunJX, NiecestroR, PhillipsG, ShenJ, LukacskoP, FriedhoffL. Comparative pharmacokinetics of lovastatin extended-release tablets and lovastatin immediate-release tablets in humans. J Clin Pharmacol. 2002;42(2):198–204. doi:10.1177/0091270022201111111831543
   PubMed Web of Science ®Google Scholar
• SteinbachJM, SeoY-E, SaltzmanWM. Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization. Acta Biomater. 2016;30:49–61. doi:10.1016/j.actbio.2015.11.02926602822
   PubMed Web of Science ®Google Scholar
• ZhangC, AnT, WangD, et al. Stepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(β-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinoma. J Control Release. 2016;226:193–204. doi:10.1016/j.jconrel.2016.02.03026896737
   PubMed Web of Science ®Google Scholar
• GuanQ, ChenW, HuX. Development of lovastatin-loaded poly(lactic acid) microspheres for sustained oral delivery: in vitro and ex vivo evaluation. Drug Des Devel Ther. 2015;9:791–798. doi:10.2147/DDDT.S76676
   PubMed Web of Science ®Google Scholar
• MooreJW, FlannerHH. Mathematical comparison of dissolution profiles. Pharm Tech. 1996;20:64–75.
   Google Scholar
• TianL, DangX-Q, WangC-S, YangP, ZhangC, WangK-Z. Effects of sodium ferulate on preventing steroid-induced femoral head osteonecrosis in rabbits. J Zhejiang Univ Sci B. 2013;14(5):426–437. doi:10.1631/jzus.B120031123645179
   PubMed Web of Science ®Google Scholar
• CastellanosIJ, FloresG, GriebenowK. Effect of the molecular weight of poly(ethylene glycol) used as emulsifier on α-chymotrypsin stability upon encapsulation in PLGA microspheres. J Pharm Pharmacol. 2005;57(10):1261–1269. doi:10.1211/jpp.57.10.000416259754
   PubMed Web of Science ®Google Scholar
• LiG, YaoL, LiJ, QinX, QiuZ, ChenW. Preparation of poly(lactide-co-glycolide) microspheres and evaluation of pharmacokinetics and tissue distribution of BDMC-PLGA-MS in rats. Asian J Pharm Sci. 2018;13(1):82–90. doi:10.1016/j.ajps.2017.09.00232104381
   PubMed Web of Science ®Google Scholar
• GuB, SunX, PapadimitrakopoulosF, BurgessDJ. Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere/PVA hydrogel composites. J Control Release. 2016;228:170–178. doi:10.1016/j.jconrel.2016.03.01126965956
   PubMed Web of Science ®Google Scholar
• FreibergS, ZhuXX. Polymer microspheres for controlled drug release. Int J Pharm. 2004;282(1–2):1–18. doi:10.1016/j.ijpharm.2004.04.01315336378
   PubMed Web of Science ®Google Scholar
• MalipeddiVR, AwasthiR, DuaK. Formulation and evaluation of controlled release ethylcellulose and polyethylene glycol microspheres containing metoprolol tartrate.. Intervent Med App Sci. 2016;8(2):60–67. doi:10.1556/1646.8.2016.2.6
   Google Scholar
• AhnfeltE, SjögrenE, HanssonP, LennernasH. In Vitro Release Mechanisms of Doxorubicin From a Clinical Bead Drug-Delivery System. J Pharm Sci. 2016;105(11):3387–3398. doi:10.1016/j.xphs.2016.08.01127663384
   PubMed Web of Science ®Google Scholar
• MahboubianA, HashemeinSK, MoghadamS, AtyabiaF, DinarvandR. Preparation and In-vitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline.. Iran J Pharm Res. 2010;9(4):369–378.24381601
   PubMed Web of Science ®Google Scholar
• RajamannanNM, SubramaniamM, SpringettM, et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 2002;105(22):2660–2665. doi:10.1161/01.CIR.0000017435.87463.7212045173
   PubMed Web of Science ®Google Scholar
• HongW, WeiZ, QiuZ, et al. Atorvastatin promotes bone formation in aged apoE–/– mice through the Sirt1–Runx2 axis. J Orthop Surg Res. 2020;15(1):303. doi:10.1186/s13018-020-01841-032762716
   PubMed Web of Science ®Google Scholar
• NishidaK, YamamotoT, MotomuraG, JingushiS, IwamotoY. Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits: a preliminary histological study. Clin Orthop Relat Res. 2008;466(5):1054–1058. doi:10.1007/s11999-008-0189-418350345
   PubMed Web of Science ®Google Scholar